Akero Therapeutics (AKRO) had the highest return between August 2, 2022 and September 30, 2022 by a mid-cap US stock, returning 220%.
| ASSET | DATE | % RETURN |
|---|---|---|
Akero Therapeutics (AKRO) | 8/2/2022 - 9/30/2022 | 220.02% |
Terns Pharmaceuticals (TERN) | 8/2/2022 - 9/30/2022 | 200.51% |
Rhythm Pharmaceuticals (RYTM) | 8/2/2022 - 9/30/2022 | 87.88% |
Applied Opt (AAOI) | 8/2/2022 - 9/30/2022 | 60.95% |
Viridian Therapeutics (VRDN) | 8/2/2022 - 9/30/2022 | 51.81% |
Wave Life Sciences (WVE) | 8/2/2022 - 9/30/2022 | 51.68% |
Bausch Health Companies (BHC) | 8/2/2022 - 9/30/2022 | 48.81% |
Xometry (XMTR) | 8/2/2022 - 9/30/2022 | 47.93% |
Cogent Biosciences (COGT) | 8/2/2022 - 9/30/2022 | 46.13% |
International Seaways (INSW) | 8/2/2022 - 9/30/2022 | 43.63% |
Immunovant (IMVT) | 8/2/2022 - 9/30/2022 | 43.08% |
Genius Sports (GENI) | 8/2/2022 - 9/30/2022 | 39.02% |
Immunitybio (IBRX) | 8/2/2022 - 9/30/2022 | 38.44% |
Weatherford International (WFRD) | 8/2/2022 - 9/30/2022 | 38.35% |
Nuvalent (NUVL) | 8/2/2022 - 9/30/2022 | 36.04% |
Palomar (PLMR) | 8/2/2022 - 9/30/2022 | 35.71% |
Clearwater Analytics (CWAN) | 8/2/2022 - 9/30/2022 | 34.64% |
Spyre Therapeutics (SYRE) | 8/2/2022 - 9/30/2022 | 33.16% |
Kiniksa Pharmaceuticals (KNSA) | 8/2/2022 - 9/30/2022 | 32.78% |
Melco Resorts & Entertainment (MLCO) | 8/2/2022 - 9/30/2022 | 32.6% |
Wix (WIX) | 8/2/2022 - 9/30/2022 | 31.32% |
Recursion Pharmaceuticals (RXRX) | 8/2/2022 - 9/30/2022 | 29.6% |
Corporacion America Airports (CAAP) | 8/2/2022 - 9/30/2022 | 28.19% |
Intapp (INTA) | 8/2/2022 - 9/30/2022 | 27.18% |
Transportadora de Gas del Sur SA ADR (TGS) | 8/2/2022 - 9/30/2022 | 26.8% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
